Detalhe da pesquisa
1.
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial.
Am Heart J
; 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740532
2.
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial.
J Card Fail
; 30(4): 525-537, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37820896
3.
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial.
Eur Heart J
; 44(31): 2947-2962, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217188
4.
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.
Lancet
; 400(10367): 1938-1952, 2022 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356631
5.
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre-Cardiogenic Shock.
J Card Fail
; 29(7): 1097-1103, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075941
6.
Reduced congestion and improved response to a fluid/sodium challenge in chronic heart failure patients after initiation of sacubitril/valsartan: The NATRIUM-HF study.
Eur J Heart Fail
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721803
7.
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial.
Circ Heart Fail
; 17(4): e011221, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445950
8.
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial.
JAMA Cardiol
; 9(2): 114-124, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38150260
9.
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial.
Eur J Heart Fail
; 26(3): 638-651, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444216
10.
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk.
JACC Heart Fail
; 2024 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739123
11.
Global differences in acute heart failure treatment: analysis of the STRONG-HF site feasibility questionnaire.
ESC Heart Fail
; 10(4): 2236-2247, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076782
12.
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction.
J Am Coll Cardiol
; 81(22): 2131-2144, 2023 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37257948
13.
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trial.
Eur J Heart Fail
; 25(7): 1145-1155, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246591
14.
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial.
Eur J Heart Fail
; 25(7): 1156-1165, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191154
15.
Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trial.
Eur J Heart Fail
; 25(11): 1994-2006, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728038
16.
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure.
Eur J Heart Fail
; 25(12): 2230-2242, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905361
17.
Safety and efficacy of istaroxime in patients with acute heart failure-related pre-cardiogenic shock - a multicentre, randomized, double-blind, placebo-controlled, parallel group study (SEISMiC).
Eur J Heart Fail
; 24(10): 1967-1977, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867804
18.
Medical Therapy of Heart Failure with Reduced Ejection Fraction-A Call for Comparative Research.
J Clin Med
; 10(9)2021 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33919005
19.
Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
Diabetes Care
; 29(11): 2365-70, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17065669
20.
The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
Diabetes Care
; 26(3): 770-6, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12610036